Aurinia Pharmaceuticals Inc. Quarterly Interest Expense in USD from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from Q2 2022 to Q2 2024.
  • Aurinia Pharmaceuticals Inc. Interest Expense for the quarter ending June 30, 2024 was $1.2M, a 1743% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. Interest Expense for the twelve months ending June 30, 2024 was $5.19M.
  • Aurinia Pharmaceuticals Inc. annual Interest Expense for 2023 was $2.78M.
  • Aurinia Pharmaceuticals Inc. annual Interest Expense for 2022 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.19M $1.2M +$1.13M +1743% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.06M $1.28M +$1.28M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2.78M $1.31M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $1.4M +$1.4M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $65K +$65K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.